Comparison 4. HCQ versus febuxostat for treatment.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
4.1 Death due to any cause | 1 | 54 | Risk Ratio (M‐H, Random, 95% CI) | Not estimable |
4.2 Admission to hospital | 1 | 54 | Risk Ratio (M‐H, Random, 95% CI) | 1.16 [0.26, 5.24] |